Changes in the Diaphragm Lipid Content after Administration of Streptozotocin and High-Fat Diet Regime

The diaphragm is a dome-shaped skeletal muscle indispensable for breathing. Its activity contributes up to 70% of the total ventilatory function at rest. In comparison to other skeletal muscles, it is distinguished by an oxidative phenotype and uninterrupted cyclic contraction pattern. Surprisingly,...

Full description

Saved in:
Bibliographic Details
Main Authors: Bartlomiej Lukaszuk, Agnieszka Miklosz, Malgorzata Zendzian-Piotrowska, Beata Wojcik, Jan Gorski, Adrian Chabowski
Format: Article
Language:English
Published: Wiley 2017-01-01
Series:Journal of Diabetes Research
Online Access:http://dx.doi.org/10.1155/2017/3437169
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832563615548309504
author Bartlomiej Lukaszuk
Agnieszka Miklosz
Malgorzata Zendzian-Piotrowska
Beata Wojcik
Jan Gorski
Adrian Chabowski
author_facet Bartlomiej Lukaszuk
Agnieszka Miklosz
Malgorzata Zendzian-Piotrowska
Beata Wojcik
Jan Gorski
Adrian Chabowski
author_sort Bartlomiej Lukaszuk
collection DOAJ
description The diaphragm is a dome-shaped skeletal muscle indispensable for breathing. Its activity contributes up to 70% of the total ventilatory function at rest. In comparison to other skeletal muscles, it is distinguished by an oxidative phenotype and uninterrupted cyclic contraction pattern. Surprisingly, the research regarding diaphragm diabetic phenotype particularly in the light of lipid-induced insulin resistance is virtually nonexistent. Male Wistar rats were randomly allocated into 3 groups: control, streptozotocin-induced (STZ) type-1 diabetes, and rodents fed with high-fat diet (HFD). Additionally, half of the animals from each group were administered with myriocin, a robust, selective inhibitor of ceramide synthesis and, therefore, a potent agent ameliorating insulin resistance. Diaphragm lipid contents were evaluated using chromatography. Fatty acid transporter expression was determined by Western blot. The STZ and HFD rats had increased concentration of lipids, namely, ceramides (CER) and diacylglycerols (DAG). Interestingly, this coincided with an increased concentration of long-chain (C ≥ 16) saturated fatty acid species present in both the aforementioned lipid fractions. The CER/DAG accumulation was accompanied by an elevated fatty acid transporter expression (FATP-1 in HFD and FATP-4 in STZ). Surprisingly, we observed a significantly decreased triacylglycerol content in the diaphragms of STZ-treated rats.
format Article
id doaj-art-10e157d4f2b043b3bef10903017a1dcb
institution Kabale University
issn 2314-6745
2314-6753
language English
publishDate 2017-01-01
publisher Wiley
record_format Article
series Journal of Diabetes Research
spelling doaj-art-10e157d4f2b043b3bef10903017a1dcb2025-02-03T01:13:05ZengWileyJournal of Diabetes Research2314-67452314-67532017-01-01201710.1155/2017/34371693437169Changes in the Diaphragm Lipid Content after Administration of Streptozotocin and High-Fat Diet RegimeBartlomiej Lukaszuk0Agnieszka Miklosz1Malgorzata Zendzian-Piotrowska2Beata Wojcik3Jan Gorski4Adrian Chabowski5Department of Physiology, Medical University of Bialystok, Bialystok, PolandDepartment of Physiology, Medical University of Bialystok, Bialystok, PolandDepartment of Hygiene, Epidemiology and Ergonomics, Medical University of Bialystok, Bialystok, PolandDepartment of Physiology, Medical University of Bialystok, Bialystok, PolandDepartment of Physiology, Medical University of Bialystok, Bialystok, PolandDepartment of Physiology, Medical University of Bialystok, Bialystok, PolandThe diaphragm is a dome-shaped skeletal muscle indispensable for breathing. Its activity contributes up to 70% of the total ventilatory function at rest. In comparison to other skeletal muscles, it is distinguished by an oxidative phenotype and uninterrupted cyclic contraction pattern. Surprisingly, the research regarding diaphragm diabetic phenotype particularly in the light of lipid-induced insulin resistance is virtually nonexistent. Male Wistar rats were randomly allocated into 3 groups: control, streptozotocin-induced (STZ) type-1 diabetes, and rodents fed with high-fat diet (HFD). Additionally, half of the animals from each group were administered with myriocin, a robust, selective inhibitor of ceramide synthesis and, therefore, a potent agent ameliorating insulin resistance. Diaphragm lipid contents were evaluated using chromatography. Fatty acid transporter expression was determined by Western blot. The STZ and HFD rats had increased concentration of lipids, namely, ceramides (CER) and diacylglycerols (DAG). Interestingly, this coincided with an increased concentration of long-chain (C ≥ 16) saturated fatty acid species present in both the aforementioned lipid fractions. The CER/DAG accumulation was accompanied by an elevated fatty acid transporter expression (FATP-1 in HFD and FATP-4 in STZ). Surprisingly, we observed a significantly decreased triacylglycerol content in the diaphragms of STZ-treated rats.http://dx.doi.org/10.1155/2017/3437169
spellingShingle Bartlomiej Lukaszuk
Agnieszka Miklosz
Malgorzata Zendzian-Piotrowska
Beata Wojcik
Jan Gorski
Adrian Chabowski
Changes in the Diaphragm Lipid Content after Administration of Streptozotocin and High-Fat Diet Regime
Journal of Diabetes Research
title Changes in the Diaphragm Lipid Content after Administration of Streptozotocin and High-Fat Diet Regime
title_full Changes in the Diaphragm Lipid Content after Administration of Streptozotocin and High-Fat Diet Regime
title_fullStr Changes in the Diaphragm Lipid Content after Administration of Streptozotocin and High-Fat Diet Regime
title_full_unstemmed Changes in the Diaphragm Lipid Content after Administration of Streptozotocin and High-Fat Diet Regime
title_short Changes in the Diaphragm Lipid Content after Administration of Streptozotocin and High-Fat Diet Regime
title_sort changes in the diaphragm lipid content after administration of streptozotocin and high fat diet regime
url http://dx.doi.org/10.1155/2017/3437169
work_keys_str_mv AT bartlomiejlukaszuk changesinthediaphragmlipidcontentafteradministrationofstreptozotocinandhighfatdietregime
AT agnieszkamiklosz changesinthediaphragmlipidcontentafteradministrationofstreptozotocinandhighfatdietregime
AT malgorzatazendzianpiotrowska changesinthediaphragmlipidcontentafteradministrationofstreptozotocinandhighfatdietregime
AT beatawojcik changesinthediaphragmlipidcontentafteradministrationofstreptozotocinandhighfatdietregime
AT jangorski changesinthediaphragmlipidcontentafteradministrationofstreptozotocinandhighfatdietregime
AT adrianchabowski changesinthediaphragmlipidcontentafteradministrationofstreptozotocinandhighfatdietregime